Abstract -There is a wide range of opportunities for the application of novel polymeric materials and systems in recombinant DNA and monoclonal antibody processes and products. This paper reviews and highlights such exciting possibilities.
INTRODUCTION
The ability to recombine DNA in precise ways, to insert the novel plasmid into living cells and to produce new proteins with important clinical uses has led to a new and immense scientific field as well as to a modern industrial, "biotechnological" revolution (1-4). In parallel with this significant achievement, immunologists have been able to produce useful quantities of antibodies with high purity and antigenic specificity. These antibodies are called monoclonal antibodies (MAb's). Their availability has created the possibility of many exciting and novel diagnostic and therapeutic applications (5) . These two significant developments together make up the exciting new field called biotechnology (Fig. 1) . This paper will review the present uses and future possibilities for applications of polymeric materials in biotechnology. Polymers play an important role in processing and applications of ReDNA, genetically-engineered products. Basically, ReDNA technology involves the insertion of a particular sequence of a hybrid ("gene") DNA into living cells, such as yeast or E. coli cells, where it is used as a template for the production of specific polypeptide products. The cells are usually cultured in dishes or in suspension, in a fermentor. These "genetically engineered" products must then be isolated and purified for subsequent uses. To date, most ReDNA products are single gene proteins which can function with little or no post-translational modification, e.g. attachment of carbohydrates. Figure 2 shows schematically a typical ReDNA process. This figure also shows where polymeric materials are used in many of the important steps in this process. New polymers with or without special surface treatments may be developed to improve process yields, production rates and product purity. For example, it is well known that both cell adhesion and cell motility on foreign surfaces are sensitive to surface chemistry (6) (7) (8) (9) . It is possible that replication of polypeptides within a cell could also be sensitive to the character of the foreign surface onto which the cell is adhered. Surfaces for cell culture may be used in a variety of forms (Table 2 ). Such polymer surfaces may be modified by a variety of methods which are based on generation of free radical initiator sites on the surfaces ( Fig. 3 ) (10, 11) . Plasma glow discharge treatments may be of particular interest for this application. 
from a fluid suspension; ultrafiltration may then be used to separate large and small molecules and reverse osmosis can be used to concentrate selected molecules in solution. A variety of polymer separation device configurations are possible, including flat membrane stacks, coiled, flattened membrane tubes, hollow fibers and packed beds. Figure 4 (12) shows schematically an idealized ReDNA fermentation process using several different polymeric membrane filtration systems.
This figure also shows an immobilized cell bioreactor and an immobilized enzyme reactor, to assist in product purification. Cells and enzymes (as well as other biomolecules and ligands) may be immobilized on a variety of polymeric supports, sometimes after these surfaces have been chemically modified, to provide reactable sites for the immobilization step (13-17). Table 3 polymer surfaces. Radiation grafting of reactable polymers to more inert polymer supports has been widely used to modify such supports for subsequent covalent bionolecule immobilization (10, 11) . Immobilized enzymes have certain advantages (Table 4) and there are a number of commercial processes utilizing immobilized enzymes and cells (Table 5 ). 
* Immobilized cells
It may sometimes also be desirable to utilize affinity chromatography to isolate the desired polypeptide product from a complex mixture of proteins, nucleic acids, lipids, glycosaminoglycans, etc. For this purpose specific ligands ma be immobilized on polymeric supports (Table 6 ). The availability of a wide range of monoclonal antibodies (MAb's) has also opened up possibilities for an immense variety of novel and revolutionary diagnostic and therapeutic applications, especially in clinical medicine (5) ( Table 7 ). MAb's may be prepared either A major use of MAb's is in a wide variety of immunoassay diagnostic tests. Included are assays for drug monitoring, viral diseases, sexually transmitted diseases, respiratory diseases, tissue typing, blood grouping, cell surface antigens and cancer. Most of these assays depend upon one of three types of signals, e.g. radioactivity (radioimmunoassay, RIA), fluorescence (fluorescent immunoassay, FIA), or visible color change (enzyme immunoassay, EIA, such as enzyme-linked immunosorbant assay, ELISA; enzyme-multiplied immunoassay technique, EMIT; and enzyme-membrane iinmunoassay, EMIA). NAb's may also be used therapeutically, either by themselves or as a targeting marker when conjugated to a drug or to a drugcontaining polymeric system (as microcapsules). NAb's or antigens are immobilized to polymeric surfaces (usually by physical adsorption) in many of the immunoassay systems, as well as when they (MAb's) are used as a targeting molecule for a drug delivery system. Specially treated or reactable polymer surfaces are also useful for these applications (1O,ll). (Fig. 5) A wide variety of biosensors utilize immobilized antibodies, antigens or enzymes (19) . Some of these are miniaturized extensions of conventional assay techniques, while a number are novel fiber-optic or acoustic devices. There are important contributions to be made here by polymer scientists in collaboration with physical scientists, electrical engineers and biological scientists (Fig. 6 ). --ANTIGEN --CELL --ENZYME
